Advance the Development of NK, Gamma-Delta T, Macrophage, and NKT Cell Therapies to Develop Cost-Effective Treatments for Liquid and Solid Tumors 2021 has been a game-changing year for the NK cell community. Positive clinical results have forced the field to wake up to the potential of these pioneering approaches.
30 March-01 April 2022